Phospholipase D2 anticorps (Middle Region)

N° du produit ABIN927421

Cet anticorps Lapin Polyclonal détecte spécifiquement Phospholipase D2 dans WB. Il présente une réactivité envers Humain, Rat et Boeuf (Vache).

Aperçu rapide pour Phospholipase D2 anticorps (Middle Region) (ABIN927421)

Antigène: Phospholipase D2 (PLD2)

Reactivité: Humain, Rat, Boeuf (Vache)

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Phospholipase D2 est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-Phospholipase D2 anticorps

Épitope: Middle Region

Réactivité croisée: Rat (Rattus), Boeuf (Vache)

Purification: Purified

Immunogène: PLD2 antibody was raised in rabbit using the middle region of PLD2 as the immunogen

Information d'application

Indications d'application: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

PLD2 Blocking Peptide, (ABIN937433), is also available for use as a blocking control in assays to test for specificity of this PLD2 antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Détails sur Phospholipase D2

Antigène: Phospholipase D2 (PLD2)

Autre désignation: PLD2

Sujet: Phosphatidylcholine (PC)-specific phospholipases D (PLDs, EC 3.1.4.4) catalyze the hydrolysis of PC to produce phosphatidic acid and choline. Activation of PC-specific PLDs occurs as a consequence of agonist stimulation of both tyrosine kinase and G protein-coupled receptors. PC-specific PLDs have been proposed to function in regulated secretion, cytoskeletal reorganization, transcriptional regulation, and cell cycle control. Synonyms: Polyclonal PLD2 antibody, Anti-PLD2 antibody, phospholipase D2 antibody.

Pathways: Signalisation RTK, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Regulation of G-Protein Coupled Receptor Protein Signaling